CD3, CD4, CD8, CD19 and CD16/CD56 positive cells in tuberculosis infection and disease: Peculiar features in children.
CD4+
interferon
lymphocyte subsets
paediatric
tuberculosis
Journal
International journal of immunopathology and pharmacology
ISSN: 2058-7384
Titre abrégé: Int J Immunopathol Pharmacol
Pays: England
ID NLM: 8911335
Informations de publication
Date de publication:
Historique:
entrez:
9
4
2019
pubmed:
9
4
2019
medline:
30
7
2019
Statut:
ppublish
Résumé
Pathogenesis of mycobacterial infection has been extensively studied determining the fundamental role of host immunocompetence in disease progression. Cellular adaptive immunity, in particular CD4+ cells, has shown to be crucial in the host defence. A role of cytotoxic lymphocytes and humoral immunity has also been established. However, few studies have been performed in low endemic countries on immunological correlates of tuberculosis in paediatric patients. The present study aims to fill this gap analysing the distribution and the absolute values of the main lymphocyte subpopulations (CD3+, CD4+, CD8+, CD19+ and CD16+/CD56+) in the different stages of tubercular infection in human immunodeficiency virus-negative children living in low tubercular endemic countries. Results obtained in children with latent tuberculosis, active tuberculosis and healthy controls were compared. Moreover, quantitative analysis of interferon-γ levels of mitogen-induced response was carried out within the different study groups. The aim of this analysis was to enforce the comprehension of immune modifications subsequent to Mycobacterium tuberculosis infection. The major finding of our study was CD3+ and CD4+ absolute and percentage depletion in children with active tuberculosis versus healthy controls. Moreover, severe forms of active tuberculosis showed a marked reduction in the CD4+ percentage in the context of a systemic impairment which affects globally the absolute count of all peripheral lymphocyte subsets tested. A relative increase of natural killer cells was proved in infected patients, whereas no differences in B cells among the study groups were detected. Mitogen-induced interferon-γ levels were significantly higher in children with latent tuberculosis when compared to active tuberculosis and healthy controls, demonstrating effective immune activation in those patients able to control the infection.
Identifiants
pubmed: 30957643
doi: 10.1177/2058738419840241
pmc: PMC6454648
doi:
Substances chimiques
Antigens, CD19
0
CD19 molecule, human
0
CD3 Complex
0
CD56 Antigen
0
FCGR3B protein, human
0
GPI-Linked Proteins
0
NCAM1 protein, human
0
Receptors, IgG
0
Types de publication
Journal Article
Langues
eng
Pagination
2058738419840241Références
Indian Pediatr. 2000 May;37(5):489-95
pubmed: 10820541
Curr Opin Immunol. 2000 Aug;12(4):432-6
pubmed: 10899019
J Infect. 2000 Sep;41(2):167-71
pubmed: 11023763
Clin Exp Immunol. 2002 Apr;128(1):149-54
pubmed: 11982602
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12013-7
pubmed: 1465432
Cytometry B Clin Cytom. 2004 Sep;61(1):20-6
pubmed: 15351978
J Infect. 2005 Dec;51(5):408-12
pubmed: 16321653
Clin Exp Immunol. 2006 Aug;145(2):252-60
pubmed: 16879244
Mediators Inflamm. 2006;2006(2):89070
pubmed: 16883069
Iran J Allergy Asthma Immunol. 2005 Mar;4(1):23-6
pubmed: 17301419
Scand J Immunol. 2008 Jul;68(1):92-102
pubmed: 18484953
Cytokine. 2008 Aug;43(2):143-8
pubmed: 18603443
Braz J Infect Dis. 2008 Dec;12(6):483-6
pubmed: 19287835
Am J Respir Cell Mol Biol. 2011 Jul;45(1):24-30
pubmed: 20724551
Clin Dev Immunol. 2011;2011:587315
pubmed: 21253470
Eur J Med Res. 2011 Jun 21;16(6):285-8
pubmed: 21810564
Chin Med J (Engl). 2012 Jan;125(2):275-80
pubmed: 22340559
Adv Exp Med Biol. 2013;783:225-50
pubmed: 23468112
Int J Tuberc Lung Dis. 2013 Jun;17(6):825-8
pubmed: 23676170
J Immunol. 1986 Mar 1;136(5):1828-34
pubmed: 2419415
PLoS One. 2013 Dec 16;8(12):e83270
pubmed: 24358268
BMC Infect Dis. 2014;14 Suppl 1:S1
pubmed: 24564297
Mediterr J Hematol Infect Dis. 2014 Apr 07;6(1):e2014027
pubmed: 24804000
J Clin Microbiol. 2015 Feb;53(2):504-10
pubmed: 25428147
Ethiop J Health Sci. 2014 Oct;24(4):311-8
pubmed: 25489195
Tubercle. 1989 Sep;70(3):171-8
pubmed: 2575814
Hum Immunol. 2015 Nov;76(11):801-7
pubmed: 26429305
Front Immunol. 2017 Aug 14;8:967
pubmed: 28855906
Tubercle. 1987 Sep;68(3):195-200
pubmed: 3502379
Clin Exp Immunol. 1985 Apr;60(1):49-54
pubmed: 3874015
J Exp Med. 1983 Jul 1;158(1):74-83
pubmed: 6602861
Infect Immun. 1975 Jun;11(6):1174-81
pubmed: 806520
Clin Exp Immunol. 1996 Nov;106(2):312-6
pubmed: 8918578
Clin Infect Dis. 1997 May;24(5):988-91
pubmed: 9142808
Am J Clin Nutr. 1997 Aug;66(2):460S-463S
pubmed: 9250133